Shares of MasTec, Inc. (NYSE:MTZ – Get Free Report) have received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $116.23.
Several research analysts have commented on the stock. Barclays lifted their price objective on shares of MasTec from $106.00 to $130.00 and gave the stock an “overweight” rating in a research note on Monday, May 6th. The Goldman Sachs Group lifted their price objective on shares of MasTec from $88.00 to $109.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 28th. Truist Financial reissued a “hold” rating and set a $109.00 target price (up from $96.00) on shares of MasTec in a research note on Monday, May 6th. Robert W. Baird boosted their target price on shares of MasTec from $89.00 to $110.00 and gave the company a “neutral” rating in a research note on Monday, May 6th. Finally, Citigroup boosted their target price on shares of MasTec from $99.00 to $104.00 and gave the company a “buy” rating in a research note on Monday, April 22nd.
Insider Activity at MasTec
Hedge Funds Weigh In On MasTec
A number of large investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its holdings in MasTec by 64.9% in the second quarter. GAMMA Investing LLC now owns 366 shares of the construction company’s stock worth $39,000 after purchasing an additional 144 shares in the last quarter. Boston Partners bought a new position in MasTec in the first quarter worth about $748,000. Cetera Advisors LLC bought a new position in MasTec in the first quarter worth about $268,000. Community Trust & Investment Co. increased its holdings in shares of MasTec by 0.6% during the first quarter. Community Trust & Investment Co. now owns 237,165 shares of the construction company’s stock valued at $22,116,000 after acquiring an additional 1,402 shares in the last quarter. Finally, Second Line Capital LLC increased its holdings in shares of MasTec by 0.8% during the first quarter. Second Line Capital LLC now owns 30,026 shares of the construction company’s stock valued at $2,800,000 after acquiring an additional 225 shares in the last quarter. 78.10% of the stock is currently owned by institutional investors.
MasTec Stock Down 2.0 %
NYSE MTZ opened at $100.92 on Wednesday. The company has a quick ratio of 1.27, a current ratio of 1.31 and a debt-to-equity ratio of 0.94. The company has a fifty day moving average of $105.52 and a two-hundred day moving average of $87.86. The firm has a market capitalization of $8.02 billion, a price-to-earnings ratio of -720.86 and a beta of 1.65. MasTec has a 52 week low of $44.65 and a 52 week high of $123.33.
MasTec (NYSE:MTZ – Get Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The construction company reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.56) by $0.33. The company had revenue of $2.69 billion during the quarter, compared to analyst estimates of $2.62 billion. MasTec had a negative net margin of 0.09% and a positive return on equity of 6.19%. On average, analysts predict that MasTec will post 2.58 earnings per share for the current year.
MasTec Company Profile
MasTec, Inc, an infrastructure construction company, provides engineering, building, installation, maintenance, and upgrade services for communications, energy, utility, and other infrastructure primarily in the United States and Canada. It operates through five segments: Communications, Clean Energy and Infrastructure, Oil and Gas, Power Delivery, and Other.
Featured Articles
- Five stocks we like better than MasTec
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- RXO Shares Surge Following New Acquisition Deal
- What is MarketRankā¢? How to Use it
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for MasTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MasTec and related companies with MarketBeat.com's FREE daily email newsletter.